21524 Federal Register / Vol. 60, No. 84 / Tuesday, May 2, 1995 / Notices

national banking association, under the

name of Citizens Bank of Illinois.

2. Mercantile Bancorporation, Inc. St.

Louis, Missouri; to acquire 100 percent

of the voting shares of Amerifirst

Bancorporation, Inc., Sikeston,

Missouri.

C. Federal Reserve Bank of Dallas

(Genie D. Short, Vice President) 2200

North Pearl Street, Dallas, Texas 75201-

2272:

1. Baylor Bancshares, Inc., Seymour,

Texas, and Baylor/Delaware Corp.,

Wilmington, Delaware; to acquire 100

percent of the voting shares of Memphis

State Bank, Memphis, Texas.

Board of Governors of the Federal Reserve

System, April 26, 1995.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95–10722 Filed 5–1–95; 8:45 am]

BILLING CODE 6210–01–F

Grimes County Capital Corporation;

Notice of Application To Engage de

novo in Permissible Nonbanking

Activities

The company listed in this notice has

filed an application under § 225.23(a)(1)

of the Board’s Regulation Y (12 CFR

225.23(a)(1)) for the Board’s approval

under section 4(c)(8) of the Bank

Holding Company Act (12 U.S.C.

1843(c)(8)) and § 225.21(a) of Regulation

Y (12 CFR 225.21(a)) to commence or to

engage de novo, either directly or

through a subsidiary, in a nonbanking

activity that is listed in § 225.25 of

Regulation Y as closely related to

banking and permissible for bank

holding companies. Unless otherwise

noted, such activities will be conducted

throughout the United States.

The application is available for

immediate inspection at the Federal

Reserve Bank indicated. Once the

application has been accepted for

processing, it will also be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing on the

question whether consummation of the

proposal can ‘‘reasonably be expected to

produce benefits to the public, such as

greater convenience, increased

competition, or gains in efficiency, that

outweigh possible adverse effects, such

as undue concentration of resources,

decreased or unfair competition,

conflicts of interests, or unsound

banking practices.’’ Any request for a

hearing on this question must be

accompanied by a statement of the

reasons a written presentation would

not suffice in lieu of a hearing,

identifying specifically any questions of

fact that are in dispute, summarizing the

evidence that would be presented at a

hearing, and indicating how the party

commenting would be aggrieved by

approval of the proposal.

Comments regarding the application

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than May 16, 1995.

A. Federal Reserve Bank of Dallas

(Genie D. Short, Vice President) 2200

North Pearl Street, Dallas, Texas 75201-

2272:

1. Grimes County Capital Corporation,

doing business as CSB Mortgage

Services, Houston, Texas; to engage de

novo in making and servicing mortgage

loans or other extensions of credit for

the account of others, pursuant to §

225.25(b)(1)(iii) of the Board’s

Regulation Y. The geographic scope for

these activities is Texas.

Board of Governors of the Federal Reserve

System, April 26, 1995.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95–10723 Filed 5–1–95; 8:45 am]

BILLING CODE 6210–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

SUMMARY: Notice is hereby given that

the Office of Research Integrity (ORI)

has made final findings of scientific

misconduct in the following case:

Denise R. Conrad, University of Iowa:

The Division of Research Investigations

(DRI) of the Office of Research Integrity

(ORI) reviewed an investigation

conducted by the University of Iowa

into possible scientific misconduct on

the part of Ms. Denise R. Conrad,

formerly a Research Assistant in the

Department of Preventive Medicine,

College of Medicine. ORI found that Ms.

Conrad committed scientific

misconduct by fabricating or falsifying

data on questionnaires in biomedical

research supported by Public Health

Service grant R01 ES05653, ‘‘Residential

Radon and Lung Cancer Case-Control

Study.’’ Ms. Conrad has accepted the

ORI findings and agreed to a Voluntary

Exclusion Agreement under which Ms.

Conrad is not eligible to apply for or

receive any Federal grant or contract

funds for a three-year period beginning

April 10, 1995. The fabricated or

falsified data did not appear in any

publication.

FOR FURTHER INFORMATION, CONTACT:

Director, Division of Research

Investigations, Office of Research

Integrity, 301–443–5330.

Lyle W. Bivens,

Director, Office of Research Integrity.

[FR Doc. 95–10762 Filed 5–1–95; 8:45 am]

BILLING CODE 4160–17–P

Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

SUMMARY: Notice is hereby given that

the Office of Research Integrity (ORI)

has made final findings of scientific

misconduct in the following case:

Catherine Coyle, ISOLAB, Inc. An

investigation conducted by the ISOLAB

found that Ms. Coyle, a former

laboratory technician, falsified and

misreported the results of assays for

fetal hemoglobin data generated for

Johns Hopkins’ Multicenter Study of

Hydroxyurea in Sickle Cell Anemia in

biomedical research supported by

Public Health Service funds under a

cooperative agreement. Ms. Coyle

admitted that she misrepresented data

submitted to the Johns Hopkins clinical

hydroxyurea study. There were no

publications involved. Ms. Coyle

executed a Voluntary Exclusion and

Settlement Agreement in which she has

agreed not to apply for Federal grant or

contract funds and will not serve on

PHS advisory committees, boards or

peer review groups for a three-year

period beginning March 27, 1995.

FOR FURTHER INFORMATION, CONTACT:

Director, Division of Research

Investigations Office of Research

Integrity, 301–443–5330.

Lyle W. Bivens,

Director, Office of Research Integrity.

[FR Doc. 95–10763 Filed 5–1–95; 8:45 am]

BILLING CODE 4160–17–P

Centers for Disease Control and

Prevention

Advisory Committee for EnergyRelated Epidemiologic Research:

Cancellation of Meeting

This notice announces the

cancellation of a previously announced

meeting.

Federal Notice Citation of Previous

Announcement: 60 FR 19264, April 17, 1995.

Previously Announced Times and Dates:

9 a.m.–5 p.m., May 4, 1995, 9 a.m.–12

noon, May 5, 1995.

Change In the Meeting: This meeting has

been canceled.